Health informatics — Requirements for international machine-readable coding of medicinal product package identifiers
Introduction: Globally, healthcare regulators, medicinal product suppliers, and healthcare providers, among others, are facing increased pressure to ensure a more secure and safer supply chain for medicinal products. The primary objective is to ensure optimal patient safety outcomes. Organizations such as the World Health Organization (WHO), the European Union and the US Congress, along with many other healthcare organizations, are also seeking robust systems that will deliver outcomes to enhance overall supply chain integrity, to prevent product falsification and to improve patient safety, especially at the point of care. Machine-readable coding is a technology capable of achieving these stated outcomes. Therefore, the core purpose of this document is to provide requirements for machine-readable coding based on globally harmonized and interoperable standards for wide scale international implementation, such as GS1 System or UDI for medical devices. This document outlines the requirements to implement international machine-readable coding on medicinal product packages in the healthcare supply chain; this process cannot be isolated from more general identification practice with medical devices or other categories of products. It assists all stakeholders implement, use, and optimize automatic identification and data capture (AIDC) technologies in their respective enterprises with a particular attention to health informatics. In that respect, this document complements ISO 11615; for example,
Scope: This document provides requirements on identification and labelling of medicinal products from the point of manufacturing of packaged medicinal product to the point of dispensing the product. This document outlines commonly accepted international practices for automatic identification and data capture (AIDC) barcoding solutions for applications and applies to manufacturers, distributors, healthcare facilities and all parties involved in labelling and distribution of packaged medicinal products. These users can, however, consider the coding interoperability requirements for other AIDC technologies, e.g. radio frequency identification (RFID); that technology is not addressed in this document except as for information.